🌍 300 million people worldwide live with a rare disease. 👶 Up to 75% are children. 💊 Only 5% of rare diseases have an FDA-approved therapy. The JAX Rare Disease Translational Center is committed to changing these outcomes. Led by Vice President Cat Lutz, the team of 60 scientists and staff are advancing rare disease research—bringing targeted therapies from the lab to the clinic faster. ➡️ Learn more about the RDTC below and here: https://www.jax.org/research-and-faculty/research-centers/rare

For nearly a century, JAX scientists have explored the genetic code to uncover the causes of disease and accelerate breakthroughs in medicine. From precision treatments to cutting-edge research models, JAX is turning bold ideas into real-world impact, improving outcomes for patients and families worldwide. Join us as we reveal how JAX is shaping the future of medicine—one breakthrough at a time. Learn more at www.jax.org | The Jackson Laboratory